The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

Switching From Tirzepatide to semaglutide for weight loss? This article was reviewed by Lynn Marie Morski, MD, JD. Key takeaways: You can switch from tirzepatide to ...

How Long Does It Take for Semaglutide to Work? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide is the active ingredient in the weight loss medication Wegovy and the ...

FDA has approved Wegovy pill, offering oral alternative to injections for obesity, delivering 14% average weight loss over 64 ...

Novo Nordisk's long game on weight loss drugs sparks hope in science, but the Street is impatient Novo Nordisk has had a ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

TAMPA (BLOOM) – Weight loss journeys are often fraught with challenges, but recent advancements in medications like GLP-1 agonists, such as semaglutide and tirzepatide, offer new hope. To better ...

Overweight and obese people with heart disease were less likely to die during a three-year trial if taking semaglutide, a study published Friday found. Adults with cardiovascular disease and excess ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...